Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Anti-D titration |
Has measured component |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
D blood group antibody identification |
Has measured component |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
rhogam-screening |
Has measured component |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D titration |
Component |
True |
Blood group antibody D |
Inferred relationship |
Some |
1 |
D blood group antibody identification |
Component |
True |
Blood group antibody D |
Inferred relationship |
Some |
1 |
rhogam-screening |
Component |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
bivirkning af anti-D (Rh) immunglobulin |
Causative agent |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
allergi over for anti-D (Rh) immunglobulin |
Causative agent |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
anti-D (Rh) immunglobulin 1250 IE/ml injektionsvæske, opløsning, 1 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
anti-D (Rh) immunglobulin 250 IE injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
anti-D (Rh) immunglobulin 500 IE injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
anti-D (Rh) immunglobulin 2500 IE injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
anti-D (Rh) immunglobulin 5000 IE injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
anti-D (Rh) immunglobulin 600 IE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
anti-D (Rh) immunglobulin 1500 IE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Rh anti-D immunglobulin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
anti-D (Rh) immunglobulin 5000 IE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
anti-D (Rh) immunglobulin injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
anti-D (Rh) immunglobulin 1500 IEi fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
anti-D (Rh) immunglobulin 1500 IE, fyldt 2 ml sprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D-globulin, ikke nærmere specificeret |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Intravenøs infusion af Rh-immunglobulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Intramuskulær injektion af Rh-immunglobulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Injektion af rRhD-immunglobulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Indgift af RhD-immunglobulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Anti-D-globulin, ikke nærmere specificeret |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Intramuskulær injektion af Rh-immunglobulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Injektion af rRhD-immunglobulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Intravenøs infusion af Rh-immunglobulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Indgift af RhD-immunglobulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Indgift af RhD-immunglobulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Anti-D-globulin, ikke nærmere specificeret |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Intramuskulær injektion af Rh-immunglobulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Intravenøs infusion af Rh-immunglobulin |
Direct substance |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
allergi over for anti-D (Rh) immunglobulin |
Causative agent |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Anti-D (Rh) immunoglobulin 1500iu powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D (Rh) immunoglobulin 5000iu powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Anti-D (Rh) immunoglobulin 600iu powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
|
Product containing blood group antibody D in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Human anti-D immunoglobulin |
Is a |
True |
Blood group antibody D |
Inferred relationship |
Some |
|
Product containing only blood group antibody D (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Product containing only blood group antibody D in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Product containing precisely blood group antibody D 1136 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Product containing precisely blood group antibody D 1136 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Rho(D) immune globulin screening (procedure) |
Component |
True |
Blood group antibody D |
Inferred relationship |
Some |
1 |
Anti-D isoimmunisation affecting pregnancy |
Causative agent |
True |
Blood group antibody D |
Inferred relationship |
Some |
1 |